FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

36914911000001102: Gliclazide 160mg tablets (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 17-Apr 2019. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
113208801000001119 Gliclazide 160mg tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
113208901000001113 Gliclazide 160mg tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

4 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Gliclazide 160mg tablets VMP non-availability indicator Not available false Inferred relationship Existential restriction modifier
Gliclazide 160mg tablets Has NHS dm+d (dictionary of medicines and devices) dose form indicator Discrete dose form indicator true Inferred relationship Existential restriction modifier
Gliclazide 160mg tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Gliclazide 160mg tablets Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route tablet.oral ontology form and route true Inferred relationship Existential restriction modifier
Gliclazide 160mg tablets Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration Oral route true Inferred relationship Existential restriction modifier
Gliclazide 160mg tablets Is a Gliclazide true Inferred relationship Existential restriction modifier
Gliclazide 160mg tablets VMP non-availability indicator Re-introduced true Inferred relationship Existential restriction modifier
Gliclazide 160mg tablets Is a Product containing gliclazide false Inferred relationship Existential restriction modifier
Gliclazide 160mg tablets Has active ingredient Gliclazide false Inferred relationship Existential restriction modifier
Gliclazide 160mg tablets Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Gliclazide 160mg tablets Has specific active ingredient Gliclazide true Inferred relationship Existential restriction modifier
Gliclazide 160mg tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Gliclazide 160mg tablets VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Gliclazide 160mg tablets Is a Virtual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Gliclazide 160mg tablets (Zentiva Pharma UK Ltd) Is a True Gliclazide 160mg tablets Inferred relationship Existential restriction modifier
Gliclazide 160mg tablets (Medihealth (Northern) Ltd) Is a True Gliclazide 160mg tablets Inferred relationship Existential restriction modifier
Gliclazide 160mg tablets (A A H Pharmaceuticals Ltd) Is a True Gliclazide 160mg tablets Inferred relationship Existential restriction modifier
Glydex 160mg tablets (Medreich Plc) Is a True Gliclazide 160mg tablets Inferred relationship Existential restriction modifier
Gliclazide 160mg tablets 28 tablet Has VMP True Gliclazide 160mg tablets Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start